L50.5
Conditions
Interventions
Group 1: Patients with cholinergic urticaria, undergoing routine diagnostic workup and provocation testing, will have additionally blood- and skin-probes taken. These will be assessed for potentially
Sponsors
Charité Campus Charité Mitte
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: patients with cholinergic urticaria or healthy controls, older than 18 years old, no other dominant skin disease, no other severe systemic disease
Exclusion criteria
Exclusion criteria: persons below 18 years, severy systemic disease, other dominant skin disease except cholinergic urticaria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood and skin samples will be taken and analyzed for singal molecules (e.g. Immunoglobulines, Cytokines, (Cytokin-)receptors, etc.) in comparison: patients v.s. healthy controls. | — |
Secondary
| Measure | Time frame |
|---|---|
| Korrelation of clinical parameter like age, sex, duration of disease, etc. with the determined laboratory markers of the skin- and bloodsamples. | — |
Countries
Germany
Contacts
Public ContactSabine Altrichter
Charite-Universitätsmedizin Berlin, Klinik für Dermatologie und Allergologie
Outcome results
None listed